Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Lupin Atlantis Holdings SA

Landis + Gyr-Strasse 1, 6300

About the sponsor

Clinical activity in myotonic dystrophy type 1 and myotonic dystrophy type 2 focuses on the symptomatic treatment of myotonia, with attention to both short-term control and longer-term management in affected adults.

  • DM1
  • DM2
  • Myotonia

The sponsor’s studies in this area address ongoing treatment needs for neuromuscular symptoms associated with inherited muscle disorders.

About Specializations

Lupin Atlantis Holdings SA runs clinical trials in conditions such as Myotonic dystrophy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Myotonic dystrophy

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mexiletine
  • Sponsor:Lupin Atlantis Holdings SA

Myotonic dystrophy

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mexiletine Hydrochloride
  • Sponsor:Lupin Atlantis Holdings SA

Myotonic dystrophy

Recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mexiletine Hydrochloride
  • Sponsor:Lupin Atlantis Holdings SA

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.